Today at Berkeley Lab

A First Step Toward CRISPR Cure of Lou Gehrig’s Disease

For the first time, University of California, Berkeley scientists have used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in mice, extending their lifespan by 25 percent. The team was led by Berkeley Lab bioscientist David Schaffer. More>

You can leave a comment. View the Comment Policy.

Leave a Reply